Lv4
600 积分 2021-07-22 加入
How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia
2天前
求助中
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
1个月前
已关闭
Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
1个月前
已完结
Efficacy of the GemOx‐R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma
1个月前
已完结
Central nervous system involvement by mantle cell lymphoma
2个月前
已完结
New BTK Inhibitors May Combat Resistance in CLL
2个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
2个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
6个月前
已完结
皖公网安备34019202002308
